ro nonpeptidic selective reversible glycoprotein iibiiia inhibitor active metabolite investigated treatment heart conditions including myocardial infarctions development ro sibrafiban discontinued following unfavorable phase iii efficacy data drug article relating blood blood forming organs stub help wikipedia expanding